The invention discloses the use of a protein with an amino acid sequence according to SEQ. ID. NO.l or a naturally occurring fragment or variant thereof for identifying infections with S. aureus in a human sample. More specifically, IgE molecules specific for SEQ. ID. NO.l are detected in the sample of the patient. Many atopic dermatitis patients have IgE specific for SEQ. ID. NO.1.